Brain-specific angiogenesis inhibitor 3
Brain-specific angiogenesis inhibitor 3 (BAI3) is a protein that in humans is encoded by the BAI3 gene. It is a member of the BAI subfamily of the GPCR superfamily of proteins. BAI3 is primarily expressed in the brain, and plays a crucial role in the regulation of angiogenesis, the process through which new blood vessels form from pre-existing vessels.
Function
BAI3 is a member of the adhesion GPCR family, which is characterized by an extended extracellular region with a variable number of protein domains coupled to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain. BAI3, like other members of the BAI subfamily, contains five Ig-like domains, a HormR domain, and a GPS domain.
BAI3 plays a significant role in the inhibition of angiogenesis. It is thought to inhibit endothelial cell proliferation and migration, thus preventing the formation of new blood vessels. This function is particularly important in the brain, where excessive angiogenesis can lead to conditions such as brain tumors and cerebral edema.
Clinical significance
Alterations in the BAI3 gene have been associated with various neurological disorders, including Alzheimer's disease and schizophrenia. In Alzheimer's disease, BAI3 is thought to play a role in the formation of amyloid plaques, which are a hallmark of the disease. In schizophrenia, alterations in the BAI3 gene may contribute to the cognitive deficits seen in the disorder.
Research
Research into BAI3 is ongoing, with a focus on understanding its role in neurological disorders and potential as a therapeutic target. Studies have suggested that BAI3 may also play a role in synaptic plasticity, the ability of synapses to strengthen or weaken over time, which is crucial for learning and memory.
See also
References
External links
- Brain-specific angiogenesis inhibitor 3 at the US National Library of Medicine Medical Subject Headings (MeSH)
This GPCR-related article is a stub. You can help WikiMD by expanding it.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD